• Guest - w'd love to know what you think about the forum! Take the 2025 Survey »

Sugarbeat Non-Invasive Glucose monitoring

They mentioned second half of this year when people met them at the Diabetes UK Professional conference in March.... Who knows whether that's true.
 
kokhongw said:
Let us know when this is available.
Click to expand...

You can register your interest here http://sugarbeat.com/. Scroll down, maybe watch the video, then you just register your eMail at the bottom.

They are definitely out to compete with Abbots FreeStyle Libre, especially as it's non invasive (see picture where you subscribe). I will be very interested in cost and clinical efficacy.
 
A few points on Sugarbeat - I wrote about it about 14 months ago: http://www.diabettech.com/cgm/nemaura-sugarbeat-competition-in-the-cgm-world-at-last/ when they were sampling every 20 minutes.

1. The MARD when used as a CGM with readings every 5 mins was awful - around 14%, so a long way from the competition, and it had only 75% of its readings in zone A of the Clarke Error grid, which is also poor, and means it is very unreliable for dosing from.

2. It's very well hidden, but you change the patch everyday and every patch needs to be calibrated with a blood test.

We've not seen any updates on performance since these numbers were published in April 2016.

Based on the data, it feels as though they are really aiming at T2s (I know a number that don't participate on line that use the Libre) and those using it for lifestyle purposes.

There has been no news of pricing but they need to price at most at £50 for 14 days use to compete with Libre. Unless they have massively improved their accuracy and a variance, there is no way I would look at one of these as an option.
 
DavidGrahamJones said:
You can register your interest here http://sugarbeat.com/. Scroll down, maybe watch the video, then you just register your eMail at the bottom.

They are definitely out to compete with Abbots FreeStyle Libre, especially as it's non invasive (see picture where you subscribe). I will be very interested in cost and clinical efficacy.
Click to expand...

:D I did, but I don't think I will get much response from there...
 
tim2000s said:
Unless they have massively improved their accuracy and a variance, there is no way I would look at one of these as an option.
Click to expand...

Yes it is unfortunate that the release results was much lower than initial number
http://www.businesswire.com/news/ho...dical-Present-Positive-Interim-Clinical-Trial
LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical Inc. (OTC BB: NMRD), ("Nemaura"), a medical device company developing the sugarBEAT® CGM System as a minimally invasive, wireless continuous glucose monitoring system, announced today that it has conducted a further interim analysis of clinical data from its ongoing 540 patient day clinical program of Type I and Type II diabetic Patients, and have determined a reduction in MARD from 18% to less than 11.8%. MARD is the Mean Absolute Relative Difference between finger-stick measurements and CGM sensor glucose values. A lower MARD indicates higher accuracy.
Click to expand...

Hopefully they are able to provide better data soon...
 
Back
Top